Thelansis

  Primary progressive multiple sclerosis (PPMS) stands out among the various forms of multiple sclerosis due to its unique characteristic of presenting as a progressively worsening condition from the onset of the disease. In contrast to relapsing-remitting multiple sclerosis (RRMS) and secondary progressive multiple sclerosis (SPMS), where symptoms come and go in episodes, PPMS is marked by a continuous deterioration of neurological function. Approximately 10% of all multiple sclerosis patients receive a diagnosis of PPMS, making it a relatively less common but impactful subtype of the disease. The precise cause of PPMS remains unknown, adding to the complexity of understanding and treating this form of multiple sclerosis. Patients typically receive a PPMS diagnosis in their mid-to-late 30s, a stage of life where the impact on daily functioning and quality of life can be particularly challenging. Noteworthy is the observation that primary progressive multiple sclerosis may exhibi...